Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |